Press "Enter" to skip to content

Analysis of Diabetes Care Devices Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Diabetes

The “Diabetes Care Devices Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Diabetes Care Devices Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Diabetes Care Devices market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Diabetes Care Devices Market Are:

  • Abbott Diabetes Care
  • Roche
  • Johnson & Johnson
  • Dexcom
  • Medtronic
  • Arkray
  • Ascensia Diabetes Care
  • Agamatrix Inc.
  • Bionime Corporation
  • Acon
  • Medisana
  • Trivida
  • Rossmax

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/13999757

    Market Overview:

  • The global diabetes care devices market is expected to register a CAGR of about 6.8% during the forecast period (2019 – 2023).
  • Asia-Pacific is anticipated to dominate the market during the forecast period, owing to rising prevalence of obesity in the region.
  • There has been a significant rise in insulin delivery systems technology, from insulin injections to insulin pumps.
  • Technological innovations and advances give much convenience in measuring the blood glucose levels. One such advancement in monitoring the blood glucose levels is established with continuous glucose monitoring devices.

    Scope of the Report:

  • The global diabetes care devices market is segmented by management devices (insulin pumps, insulin pens, syringes, cartridges, and jet injectors) and monitoring devices (self-monitoring blood glucose (hospital and personal use) and continuous glucose monitoring), and geography.

    Diabetes Care Devices Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Diabetes Care Devices market?
    • What are the key market trends impacting the growth of the global Diabetes Care Devices market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Diabetes Care Devices market?
    • What are the market opportunities and threats faced by the vendors in the global Diabetes Care Devices market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Diabetes Care Devices market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/13999757

    Key Market Trends: – Rising Prevalence of Diabetes

    As per a WHO report, the global prevalence of diabetes among adults of over 18 years accelerated from about 4.7%, in 1980, to over 8.5%, in 2014.
    Diabetes prevalence has been rising rapidly in the middle- and low-income countries. In 2015, about 1.6 million deaths were directly associated with diabetes, which was around 2.2 million in 2012.
    Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes is likely to be the seventh-leading cause of death by 2030.
    The growing prevalence of diabetes is the major driver for the global diabetes care devices market. Additionally, rising awareness regarding diabetes care, growing prevalence of obesity, and technological advancements are further driving the market for diabetes care devices.

    North America to Dominate the Monitoring Devices Segment

    The factors attributing to the North American market growth is the rising prevalence of diabetes, caused mainly due to urbanization and sedentary lifestyles.
    Asia-Pacific is anticipated to grow tremendously during the forecast period, owing to factors, such as a high prevalence of diabetes, growing obese population, and government initiatives of raising awareness regarding diabetic care.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Diabetes Care Devices Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Diabetes Care Devices.

    Purchase this Report (Price 6000 USD for single user license) – https://www.industryresearch.co/purchase/13999757

    Report Objectives:

    • Analyzing the size of the Diabetes Care Devices market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Diabetes Care Devices market.
    • Determining the key dynamics of the Diabetes Care Devices market.
    • Highlighting significant trends of the Diabetes Care Devices market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Diabetes Care Devices market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Diabetes Care Devices market.

    Detailed TOC of Diabetes Care Devices Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 Monitoring Devices
    5.1.1 Self-Monitoring Blood Glucose Devices
    5.1.1.1 By Component (Value and Volume, 2012 – 2024)
    5.1.1.1.1 Glucometer Devices
    5.1.1.1.2 Test Strips
    5.1.1.1.3 Lancets
    5.1.1.2 By End User
    5.1.1.2.1 Hospital (Value and Volume, 2012 – 2024)
    5.1.1.2.1.1 Glucometer Devices
    5.1.1.2.1.2 Test Strips
    5.1.1.2.1.3 Lancets
    5.1.1.2.2 Personal (Value and Volume, 2012 – 2024)
    5.1.1.2.2.1 Glucometer Devices
    5.1.1.2.2.2 Test Strips
    5.1.1.2.2.3 Lancets
    5.1.2 Continuous Blood Glucose Monitoring
    5.1.2.1 By Component (Value and Volume, 2012 – 2024)
    5.1.2.1.1 Sensors
    5.1.2.1.2 Receivers
    5.2 Management Devices
    5.2.1 Insulin Pump
    5.2.1.1 Insulin Pump Device
    5.2.1.2 Insulin Pump Reservoir
    5.2.1.3 Infusion Set
    5.2.2 Insulin Syringes
    5.2.3 Insulin Cartridges
    5.2.4 Disposable Pens
    5.2.5 Jet Injectors
    5.3 Geography
    5.3.1 North America
    5.3.1.1 United States (Value and Volume, 2012 – 2024)
    5.3.1.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.1.2 Canada (Value and Volume, 2012 – 2024)
    5.3.1.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.1.3 Rest of North America (Value and Volume, 2012 – 2024)
    5.3.1.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.1.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.1.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2 Europe
    5.3.2.1 France (Value and Volume, 2012 – 2024)
    5.3.2.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.2 Germany (Value and Volume, 2012 – 2024)
    5.3.2.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.3 Italy (Value and Volume, 2012 – 2024)
    5.3.2.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.4 Spain (Value and Volume, 2012 – 2024)
    5.3.2.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.5 United Kingdom (Value and Volume, 2012 – 2024)
    5.3.2.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.6 Russia (Value and Volume, 2012 – 2024)
    5.3.2.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.2.7 Rest of Europe (Value and Volume, 2012 – 2024)
    5.3.2.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.2.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.2.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3 Latin America
    5.3.3.1 Mexico (Value and Volume, 2012 – 2024)
    5.3.3.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3.2 Brazil (Value and Volume, 2012 – 2024)
    5.3.3.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.3.3 Rest of Latin America (Value and Volume, 2012 – 2024)
    5.3.3.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.3.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.3.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4 Asia-Pacific
    5.3.4.1 Japan (Value and Volume, 2012 – 2024)
    5.3.4.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.2 South Korea (Value and Volume, 2012 – 2024)
    5.3.4.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.3 China (Value and Volume, 2012 – 2024)
    5.3.4.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.4 India (Value and Volume, 2012 – 2024)
    5.3.4.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.5 Australia (Value and Volume, 2012 – 2024)
    5.3.4.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.6 Vietnam (Value and Volume, 2012 – 2024)
    5.3.4.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.7 Malaysia (Value and Volume, 2012 – 2024)
    5.3.4.7.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.7.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.7.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.8 Indonesia (Value and Volume, 2012 – 2024)
    5.3.4.8.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.8.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.8.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.9 Philippines (Value and Volume, 2012 – 2024)
    5.3.4.9.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.9.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.9.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.10 Thailand (Value and Volume, 2012 – 2024)
    5.3.4.10.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.10.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.10.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.4.11 Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
    5.3.4.11.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.4.11.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.4.11.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5 Middle East & Africa
    5.3.5.1 Saudi Arabia (Value and Volume, 2012 – 2024)
    5.3.5.1.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.1.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.2 Iran (Value and Volume, 2012 – 2024)
    5.3.5.2.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.2.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.2.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.3 Egypt (Value and Volume, 2012 – 2024)
    5.3.5.3.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.3.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.3.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.4 Oman (Value and Volume, 2012 – 2024)
    5.3.5.4.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.4.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.4.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.5 South Africa (Value and Volume, 2012 – 2024)
    5.3.5.5.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.5.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.5.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)
    5.3.5.6 Rest of Middle & Africa (Value and Volume, 2012 – 2024)
    5.3.5.6.1 By Monitoring Device (Self-Monitoring Blood Glucose, Continuous Glucose Monitoring)
    5.3.5.6.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
    5.3.5.6.3 By Company (Roche, Dexcom, Abbott, Novo Nordisk and Others)

    6 MARKET INDICATORS
    6.1 Type 1 Diabetes Population (2012-2024)
    6.2 Type 2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 COMPANY PROFILES
    7.1.1 Abbott Diabetes Care
    7.1.2 Roche
    7.1.3 Johnson & Johnson
    7.1.4 Dexcom
    7.1.5 Medtronic
    7.1.6 Arkray
    7.1.7 Ascensia Diabetes Care
    7.1.8 Agamatrix Inc.
    7.1.9 Bionime Corporation
    7.1.10 Acon
    7.1.11 Medisana
    7.1.12 Trivida
    7.1.13 Rossmax
    7.2 COMPANY SHARE ANALYSIS
    7.2.1 Roche
    7.2.2 Johnson & Johnson
    7.2.3 Abbott Diabetes Care
    7.2.4 Dexcom
    7.2.5 Medtronic
    7.2.6 Novo Nordisk
    7.2.7 Eli Lilly
    7.2.8 Sanofi
    7.2.9 Others

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Indium Tin Oxide Market 2019 Analysis By Product Type (Touch panel, Touch screen), Enterprise Size, Key Applications, End-User Sector, Sales Channel, Competitive Landscape and Growth Factors up to 2026

    Global Military Fighter Aircraft Market 2019: Industry Size & Share, Business Strategies, Growth Analysis, Regional Demand, Revenue, Key Manufacturers and 2026 Forecast Research Report,

    Alcoholic Beverages Market 2019 – Driving Factors of Key Players, Emerging Technologies, Sales Revenue, Global Size, Share, and Forecast to 2023

    e-Health Market 2019 Global Share, Growth, Size, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast to 2024

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *